Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: A pilot study

Annals of the Rheumatic Diseases

Volumn 59, Issue 7, 2000, Pages 539-543

  Dessein, P H ^a   Shipton, E A ^a   Stanwix, A E ^b   Joffe, B I ^b   Ramokgadi, J ^c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF SOUTH AFRICA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN; TRIACYLGLYCEROL; UNSATURATED FATTY ACID; URATE;

ADULT; ARTICLE; BODY MASS; CALORIC RESTRICTION; CARBOHYDRATE DIET; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DIET; DYSLIPIDEMIA; EVALUATION; GOUT; HUMAN; HYPERURICEMIA; INSULIN RESISTANCE; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; MALE; PATHOGENESIS; PILOT STUDY; PRIORITY JOURNAL; PROTEIN INTAKE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; BODY MASS INDEX; DIET, REDUCING; DIETARY FATS, UNSATURATED; DIETARY PROTEINS; FOLLOW-UP STUDIES; GOUT; HUMANS; INSULIN RESISTANCE; LIPOPROTEINS; MALE; MIDDLE AGED; OBESITY; PILOT PROJECTS; SYNDROME; URIC ACID; WEIGHT LOSS;

EID: 0033936010     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.7.539     Document Type: Article

References (29)

1. 1 Vuorinen-Markkola H, Yki-Jarvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994;78:25-9.
2. 2 Davidson MB. Clinical implications of insulin resistance syndrome. Am J Med 1995;99:420-6.
3. 3 Jeppesen J, Facchini FS, Reaven GM. Individuals with high total cholesterol/HDL ratios are insulin resistant. J Intern Med 1998;243:293-8.
4. 4 Kelly WN, Wortmann RL. Gout and hyperuricemia. In: Kelly WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology. Philadelphia: Saunders, 1997:1313-51.
5. 5 Cigolini M, Targher G, Tonoli M, Manara F, Muggeo M, De Sandre G. Hyperuricemia: relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women. Int J Obes Relat Metab Disord 1995;19:92-6.
6. 6 Emmerson BT. The management of gout. N Engl J Med 1996;334:445-51.
7. 7 Emmerson BT. Hyperlipidaemia in hyperuricaemia and gout. Ann Rheum Dis 1998;57:509-10.
8. 8 Pascual E. Management of crystal arthritis. Rheumatology 1999;38:912-16.
9. 9 Reaven GM. Do high carbohydrate diets prevent the development or attenuate the manifestations (or both) of syndrome X? A viewpoint strongly against. Curr Opin Lipidol 1997;8:23-7.
10. 10 Piatti PM, Monti F, Fermo I, Baruffaldi L, Nasser R, Santambrogio G, et al. Hypocaloric high-protein diet improves glucose oxidation and spares lean body mass: comparison to hypocaloric high-carbohydrate diet. Metabolism 1994;43:1481-7.
11. 11 Gardner CD, Kraemer HC. Monounsaturated versus polyunsaturated dietary fat and serum lipids. A meta-analysis. Arterioscler Thromb Vasc Biol 1995;15:1917-27.
12. 12 Parillo M, Rivellese AA, Ciardullo AV, Capaldo D, Giacco A, Genovese S, et al. A high-monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent diabetic patients. Metabolism 1992;41:1373-8.
13. 13 de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin J-L, Monjaud I, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994;343:1454-9.
14. 14 Sears B, Lawren B. Enter the zone. New York: Harper Collins, 1995.
15. 15 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP). JAMA 1993;269:3015-23.
16. 16 Knopp RH. Drug treatment of lipid disorders. N Engl J Med 1999;341:498-511.
17. 17 Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986;256:2835-8.
18. 18 Ramsay LE, Wallis EJ, Hag IU, Yeo WW, Jacobson PR. Sheffield table for primary prevention of cardiovascular disease. Lancet 1998;351:443-4.
19. 19 Walden CE, Retzlaff BM, Buck BL, McCann BS, Knopp RH. Lipoprotein lipid response to the National Cholesterol Education Program Step II Diet by hypercholesterolemic and combined hyperlipidemic women and men. Arterioscier Thromb Vasc Biol 1997;17:375-82.
20. 20 Nicholls A, Scott JT. Effect of weight-loss on plasma and urinary levels of uric acid. Lancet 1972;ii:1223-4.
21. 21 Puig JG, Ruilope LM. Uric acid as a cardiovascular risk factor in arterial hypertension. J Hypertens 1999;17:869-72.
22. 22 Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 1991;266:3008-11.
23. 23 Takahashi S, Yamamoti T, Moriwali Y, Tsutsumi Z, Higashirio K. Impaired lipoprotein metabolism in patients with primary gout - influence of alcohol intake and body weight. Br J Rheumatol 1994;33:731-4.
24. 24 Tinahones JF, Perez-Lindon G, C-Soriguer FJ, Pareja A, Sanchez-Guijo P, Collantes E. Dietary alterations in plasma very low density lipoprotein levels modify renal excretion of urates in hyperuricemic-hypertriglyceridemic patients. J Clin Endocrinol Metab 1997;82:1188-91.
25. 25 Dessein PH, Stanwix AE, Shipton EA, Joffe BI, van der Merwe CA. Dyslipidemia and insulin resistance in gout: sufficiently common to be considered in the evaluation and management of every patient. III. African League Against Rheumatism (AFLAR) Conference. Cape Town, South Africa, September 1999. Cape Town: Ukenza, 1999.
26. 26 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RR. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in men. Diabetologia 1985;28:412-19.
27. 27 Assmann G, Schulte H, Funke H, von Eckardstein A. The emergence of triglycerides as a significant independent risk ractor in coronary artery disease. Eur Heart J 1998;suppl M:M8-14.
28. 28 Frick MM, Elo O, Haapa K, Meinonen OP; Heinsalmi P, Helo P, et al. Helsinki Heart Study primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987;317:1237-45.
29. 29 Cohen MG, Emmerson BT. Crystal-related arthropathies. In: Klippel JH, Dieppe PA, eds. Rheumatology. Vol 8. 2nd ed. London: Mosby, 1998:section 8, 14:1-14.